Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:VSTM
Date2/2012
Raised$52M
Post IPO Valuation

General Information

Offices

Boston, USA
800 Boylston St
Suite 1555
Boston, MA, 02199
USA
Cambridge, USA
215 First St
Suite 440
Cambridge, MA, 02142
USA

People

Chief Financial Officer
President and COO
President & Chief Executive Officer
Board Of Directors
Board Of Directors
Board Of Directors
Board Of Directors
Board Of Directors
Show All People

Funding

Tags

Verastem

Verastem, Inc. is a private biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is translating breakthrough discoveries in cancer stem cell research into new medicines for the treatment of major cancers such as breast cancer.

Recent Milestones

Videos

Screenshots

Stock Price

Sources

  1. Verastem Closes $16M Series A Financing (finsmes.com) [edit]
  2. Verastem rounds up $32M in second funding (masshightech.com) [edit]
  3. Verastem, with IPO planned, raises $20M in funding (masshightech.com) [edit]
  4. SEC (sec.gov) [edit]
  5. Former Genzyme CEO Termeer named to Verastem board (masshightech.com) [edit]
Edit This Page
Last Edited 3/6/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy